Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

Published:2008 Issue:3 Volume:119 Page:133-141
ISSN:1421-9662
Container-title:Acta Haematologica
language:en
Short-container-title:Acta Haematol

Author:

Vichinsky Elliott,Pakbaz Zahra,Onyekwere Onyinye,Porter John,Swerdlow Paul,Coates Thomas,Lane Peter,Files Beatrice,Mueller Brigitta U.,Coïc Lena,Forni Gian Luca,Fischer Roland,Marks Peter,Rofail Diana,Abetz Linda,Baladi Jean-Francois

Publisher

S. Karger AG

Subject

Hematology,General Medicine

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives;Journal of Blood Medicine;2023-04

2. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia;Cochrane Database of Systematic Reviews;2023-03-06

3. Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease;Health Science Reports;2021-07-14

4. Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study;HemaSphere;2019-05-31

5. Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias;Health and Quality of Life Outcomes;2018-11-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP